Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology.

Abstract

Herkinorin is the first μ opioid (MOP) selective agonist derived from salvinorin A, a hallucinogenic natural product. Previous work has shown that, unlike other opioids, herkinorin does not promote the recruitment of β-arrestin-2 to the MOP receptor and does not lead to receptor internalization. This paper presents the first in vivo evaluation of herkinorin's antinociceptive effects in rats, using the formalin test as a model of tonic inflammatory pain. Herkinorin was found to produce a dose-dependent decrease in the number of flinches evoked by formalin. These antinociceptive effects were substantially blocked by pretreatment with the nonselective antagonist naloxone, indicating that the antinociception is mediated by opioid receptors. Contralateral administration of herkinorin did not attenuate the number of flinches evoked by formalin, indicating that its effects are peripherally restricted to the site of injection. Following chronic administration (5-day), herkinorin maintained antinociceptive efficacy in both phases of the formalin test. Furthermore, unlike morphine, herkinorin was still able to inhibit flinching in both phases of the formalin test in animals made tolerant to chronic systemic morphine treatment. Collectively, these results suggest that herkinorin may produce peripheral antinociception with decreased tolerance liability and thereby represents a promising template for the development of agents for the treatment of a variety of pain states.

• Authors: Kenneth Lamb, Kevin Tidgewell, Denise S Simpson, Laura M Bohn, Thomas E Prisinzano
• Journal: Drug and alcohol dependence (Drug Alcohol Depend) Vol. 121 Issue 3 Pg. 181-8 (Mar 01 2012) ISSN: 1879-0046 [Electronic] Ireland
• PMID: 22119134 (Publication Type: Journal Article)
• Copyright: Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Chemical References

• 9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho(2,1-c)pyran-7-carboxylic acid methyl ester
• Analgesics, Opioid
• Furans
• Pyrones
• Receptors, Opioid, mu

Topics

• Analgesics, Opioid (pharmacology, therapeutic use)
• Animals
• Furans (pharmacology, therapeutic use)
• Male
• Pain (drug therapy)
• Pain Measurement (drug effects)
• Pyrones (pharmacology, therapeutic use)
• Rats
• Rats, Sprague-Dawley
• Receptors, Opioid, mu (agonists)